Browsing by Subject "DARATUMUMAB MONOTHERAPY"

Now showing items 1-1 of 1

    • Phase I trial of isatuximab monotherapy in the treatment of refractory multiple myeloma 
      Martin, Thomas; Strickland, Stephen; Glenn, Martha; Charpentier, Eric; Guillemin, Helene; Hsu, Karl; Mikhael, Joseph (Blood Cancer Journal, 2019-03-29)
      This phase I dose-escalation/expansion study evaluated isatuximab (anti-CD38 monoclonal antibody) monotherapy in patients with relapsed/refractory multiple myeloma (RRMM). Patients progressing on or after standard therapy ...